Cellebrite DI Ltd.
CLBT | NASDAQ
$11.56
-$0.06 (-0.52%)
At close: Sep 21, 2026, 4:00 PM ET
$11.58
+$0.02 (+0.17%)
Pre-market:
Sep 22, 2026, 6:30 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 56.34 | -16.32 | -20.14 | 6.81 | 16.04 | -211.02 |
PEG Ratio | -0.46 | -0.08 | 0.12 | 0.24 | -0.01 | 30.57 |
PS Ratio | 9.58 | 11.50 | 5.07 | 2.94 | 4.69 | 10.11 |
PB Ratio | 9.41 | 13.73 | 48.13 | 10.78 | -15.75 | 30.89 |
P/FCF Ratio | 29.25 | 37.96 | 17.49 | 69.31 | 41.33 | 32.67 |
P/OCF Ratio | 26.96 | 34.91 | 16.14 | 38.71 | 32.03 | 29.63 |
OCF/S Ratio | 35.52 | 32.94 | 31.39 | 7.60 | 14.64 | 34.12 |
Debt / Equity Ratio | 0.05 | 0.03 | 0.41 | 0.21 | n/a | n/a |
Quick Ratio | 1.54 | 1.89 | 1.62 | 1.38 | 1.43 | 2 |
Current Ratio | 1.56 | 1.92 | 1.66 | 1.42 | 1.46 | 2.03 |
Asset Turnover | 0.51 | 0.58 | 0.61 | 0.67 | 0.72 | 0.53 |
Interest Coverage | n/a | 0.16 | n/a | 7.01 | 90.34 | 6.48 |
Return on Equity | 16.17% | -84.22% | -237.05% | 163.55% | -97.34% | 9.06% |
Return on Assets | 8.34% | -40.98% | -15.22% | 29.95% | 21.01% | 1.59% |
Return on Invested Capital | 10.02% | 14.26% | 11.19% | 0.52% | 7.83% | 2.28% |
Dividend Yield | n/a | n/a | n/a | n/a | 8.66% | 0.51% |
Payout Ratio | n/a | n/a | n/a | n/a | 140.06% | 172.98% |
FCF Payout Ratio | n/a | n/a | n/a | n/a | 465.96% | 18.85% |
Gross Profit Margin | 84.20% | 84.40% | 83.63% | 81.25% | 82.72% | 80.57% |
Net Profit Margin | 16.47% | -70.54% | -24.95% | 44.63% | 28.99% | 2.97% |
Pretax Profit Margin | 19.06% | -68.79% | -23.24% | 44.62% | 33.42% | 5.85% |
Operating Profit Margin | 13.98% | 14.18% | 10.22% | 0.39% | 5.61% | 4.73% |
FCF Margin | 32.74% | 30.30% | 28.96% | 4.25% | 11.35% | 30.95% |
EBITDA Margin | 21.67% | -66.14% | -20.12% | 48.07% | 36.33% | 8.86% |
Add to Watchlist
Select watchlists to add or remove CLBT